Group One Trading’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-300
| Closed | -$17.2K | – | 8504 |
|
|
2025
Q3 | $17.2K | Sell |
300
-100
| -25% | -$5.76K | ﹤0.01% | 6811 |
|
|
2025
Q2 | $23.6K | Buy |
400
+100
| +33% | +$6.46K | ﹤0.01% | 6155 |
|
|
2025
Q1 | $22K | Buy |
+300
| New | +$24.8K | ﹤0.01% | 5760 |
|
|
2024
Q4 | – | Sell |
-200
| Closed | -$14.3K | – | 7511 |
|
|
2024
Q3 | $14.3K | Sell |
200
-1,200
| -86% | -$84.7K | ﹤0.01% | 5419 |
|
|
2024
Q2 | $95.9K | Sell |
1,400
-300
| -18% | -$17.9K | ﹤0.01% | 3999 |
|
|
2024
Q1 | $91.2K | Sell |
1,700
-10,700
| -86% | -$575K | ﹤0.01% | 4231 |
|
|
2023
Q4 | $661K | Sell |
12,400
-4,100
| -25% | -$200K | ﹤0.01% | 2835 |
|
|
2023
Q3 | $819K | Sell |
16,500
-66,000
| -80% | -$3.69M | ﹤0.01% | 2463 |
|
|
2023
Q2 | $4.91M | Buy |
82,500
+10,500
| +15% | +$598K | 0.02% | 964 |
|
|
2023
Q1 | $4.08M | Buy |
72,000
+42,900
| +147% | +$2.75M | 0.01% | 969 |
|
|
2022
Q4 | $2.16M | Buy |
29,100
+22,800
| +362% | +$1.55M | 0.01% | 1758 |
|
|
2022
Q3 | $375K | Sell |
6,300
-13,900
| -69% | -$837K | ﹤0.01% | 3509 |
|
|
2022
Q2 | $1.13M | Buy |
20,200
+16,300
| +418% | +$1.07M | ﹤0.01% | 2631 |
|
|
2022
Q1 | $288K | Buy |
3,900
+3,500
| +875% | +$243K | ﹤0.01% | 4414 |
|
|
2021
Q4 | $29K | Sell |
400
-3,100
| -89% | -$225K | ﹤0.01% | 6742 |
|
|
2021
Q3 | $268K | Sell |
3,500
-17,500
| -83% | -$1.41M | ﹤0.01% | 4867 |
|
|
2021
Q2 | $1.63M | Sell |
21,000
-1,800
| -8% | -$128K | ﹤0.01% | 2864 |
|
|
2021
Q1 | $1.41M | Buy |
22,800
+19,400
| +571% | +$1.23M | ﹤0.01% | 2840 |
|
|
2020
Q4 | $222K | Sell |
3,400
-4,100
| -55% | -$236K | ﹤0.01% | 3986 |
|
|
2020
Q3 | $371K | Sell |
7,500
-2,500
| -25% | -$129K | ﹤0.01% | 3111 |
|
|
2020
Q2 | $477K | Sell |
10,000
-38,700
| -79% | -$1.87M | ﹤0.01% | 2682 |
|
|
2020
Q1 | $2.07M | Buy |
48,700
+47,300
| +3,379% | +$2.34M | 0.02% | 1020 |
|
|
2019
Q4 | $82K | Buy |
+1,400
| New | +$76K | ﹤0.01% | 3761 |
|
|
2018
Q4 | – | Sell |
-1,600
| Closed | -$91K | – | 5052 |
|
|
2018
Q3 | $91K | Sell |
1,600
-8,100
| -84% | -$426K | ﹤0.01% | 3599 |
|
|
2018
Q2 | $489K | Buy |
9,700
+9,500
| +4,750% | +$495K | ﹤0.01% | 2307 |
|
|
2018
Q1 | $10K | Sell |
200
-5,900
| -97% | -$277K | ﹤0.01% | 4313 |
|
|
2017
Q4 | $251K | Buy |
6,100
+3,500
| +135% | +$123K | ﹤0.01% | 2783 |
|
|
2017
Q3 | $77K | Sell |
2,600
-12,400
| -83% | -$379K | ﹤0.01% | 3391 |
|
|
2017
Q2 | $497K | Buy |
15,000
+5,200
| +53% | +$163K | 0.01% | 1972 |
|
|
2017
Q1 | $290K | Buy |
+9,800
| New | +$267K | ﹤0.01% | 2256 |
|
|
2016
Q4 | – | Sell |
-10,200
| Closed | -$230K | – | 4559 |
|
|
2016
Q3 | $230K | Buy |
10,200
+6,100
| +149% | +$143K | ﹤0.01% | 2370 |
|
|
2016
Q2 | $98K | Sell |
4,100
-11,400
| -74% | -$273K | ﹤0.01% | 2875 |
|
|
2016
Q1 | $368K | Buy |
+15,500
| New | +$379K | 0.01% | 1917 |
|
|
2015
Q4 | – | Sell |
-14,900
| Closed | -$308K | – | 4852 |
|
|
2015
Q3 | $308K | Buy |
+14,900
| New | +$377K | ﹤0.01% | 2179 |
|
|
2015
Q2 | – | Sell |
-300
| Closed | -$8K | – | 4963 |
|
|
2015
Q1 | $8K | Sell |
300
-3,100
| -91% | -$75.5K | ﹤0.01% | 4223 |
|
|
2014
Q4 | $81K | Buy |
3,400
+3,200
| +1,600% | +$70.8K | ﹤0.01% | 3009 |
|
|
2014
Q3 | $4K | Sell |
200
-100
| -33% | -$2.06K | ﹤0.01% | 4786 |
|
|
2014
Q2 | $7K | Sell |
300
-2,700
| -90% | -$65.1K | ﹤0.01% | 4649 |
|
|
2014
Q1 | $80K | Buy |
+3,000
| New | +$71.3K | ﹤0.01% | 3257 |
|
|
2013
Q3 | – | Sell |
-1,300
| Closed | -$22K | – | 5356 |
|
|
2013
Q2 | $22K | Buy |
+1,300
| New | +$20.1K | ﹤0.01% | 4017 |
|
Other funds holding GMED
VCM
VPM
SC
Group One Trading's GMED Position: Q4 2025 in Review
Group One Trading sold out of Globus Medical (GMED) in Q4 2025, closing a stake of 447 shares — an estimated $25.6K sold.
Group One Trading first reported a position in GMED in Q2 2013 and held it in 22 quarters. The position peaked at $271K in Q2 2016. 561 funds tracked by Wall St. Rank hold GMED as of Q4 2025.
- Group One Trading reported no remaining Globus Medical position as of Q4 2025 after selling out during the quarter.
- Group One Trading sold 447 Globus Medical shares in Q4 2025, an estimated $25.6K.
- Group One Trading first reported a position in Globus Medical in Q2 2013 and held it in 22 quarters.
- Group One Trading's Globus Medical position peaked at $271K in Q2 2016.
- 561 funds tracked by Wall St. Rank held Globus Medical as of Q4 2025.
Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.